Special Challenges in Rare Diseases

  • Learn how the government and private sector are addressing the special challenges faced by patients and companies in the new health care environment
  • Meet individuals who face the same challenges that you do
  • Gain a better understanding of how the FDA and NIH work and how they interact with the drug and device development processes
  • Learn ways to de-risk your investments in orphan products and understand better the timelines for research and regulatory reviews

Featured Speakers Include


  • John J. Castellani: President & CEO Pharmaceutical Research and Manufacturers of America (PhRMA)


  • Peter Saltonstall: President and CEO, National Organization for Rare Disorders (NORD)
  • Mark McClellan, MD, PhD: Director, Engelberg Center for Health Care Reform and Leonard D. Schaeffer Chair in Health Policy Studies, The Brookings Institution
  • Richard H. Bagger: Senior Vice President, Corporate Affairs & Strategic Market Access, Celgene Corporation
  • Miriam O’Day: Senior Director Public Policy, Alpha-1 Foundation


  • Christopher Jennings: President, Jennings Policy Strategies

© 2017